Robotic Controllers for Motor Learning After Neurological Injuries
(HRCEML Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests robotic devices that help people improve movement after neurological injuries like strokes or spinal cord injuries. The researchers aim to develop robots that interact naturally with humans to enhance movement in the ankle, knee, and hip. These human-like robotic controllers assist in motor learning. The study involves participants who are healthy, have had a stroke, or have a spinal cord injury. Ideal candidates can walk short distances independently but struggle with speed or stability. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research in robotic rehabilitation.
Do I need to stop taking my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. However, it mentions that participants should not have concurrent medical treatments, which might imply some restrictions. It's best to discuss your specific medications with the trial coordinators.
What prior data suggests that these robotic controllers are safe for motor learning after neurological injuries?
Previous studies have found that robotic devices assist in relearning movement. These studies explored human-robot interactions. The treatments are easy to handle, with no serious side effects reported. Researchers use robots to make movements feel more natural, mimicking human motion.
In these studies, robots help people regain movement after injuries like strokes or spinal cord injuries. Their safety is supported by use in other research settings without major issues. Overall, research shows these treatments are safe for humans, based on existing data and experiences.12345Why are researchers excited about this trial?
Researchers are excited about using human-like robotic controllers for motor learning after neurological injuries because these devices offer a new way to enhance physical rehabilitation. Unlike traditional therapies that rely on manual guidance and repetitive exercises, these robotic controllers provide precise, consistent support tailored to each individual's needs. The technology allows for real-time adaptation during movement, improving task performance and motor outcomes. By focusing on dyadic physical interactions, this approach aims to optimize recovery by making rehabilitation more interactive and responsive, potentially leading to faster and more effective rehabilitation outcomes.
What evidence suggests that these robotic controllers are effective for motor learning after neurological injuries?
Research has shown that robotic devices can significantly aid individuals with neurological injuries, such as those from a stroke or spinal cord injury, in improving movement. Studies have found that these devices can mimic human interactions, enhancing movement. In this trial, participants will join different treatment arms to assess the effectiveness of robotic devices. One arm involves healthy participants using an ankle robot, while another involves clinical populations using the same device. Additionally, there are arms for both healthy participants and clinical populations using a bilateral lower limb exoskeleton. These findings suggest that robotic devices could effectively help patients regain mobility.12345
Who Is on the Research Team?
Jose Pons, Ph.D
Principal Investigator
Shirley Ryan AbilityLab
Are You a Good Fit for This Trial?
This trial is for individuals aged 18-80 with normal hearing and vision, who can understand English and give informed consent. It's suitable for healthy participants as well as those post-stroke or with spinal cord injury (SCI), provided they can walk over 10m independently. People with brain lesions, neurological disorders, abnormal limb movements, or outside the height range of 3'6" to 6'2" cannot join.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Experiment A
Recruitment of healthy volunteers to model human adaptation in dyadic interactions and develop robot controllers
Experiment B
Testing robot controllers with healthy volunteers, post-stroke, and SCI participants to assess mechanical adaptation and role sharing
Experiment C
Showcasing robot controllers with post-stroke and SCI participants to observe motor learning and functional outcomes
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Human-like Robotic Controllers
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shirley Ryan AbilityLab
Lead Sponsor
U.S. National Science Foundation
Collaborator